NNV024, a novel humanized anti-CD37 antibody with enhanced ADCC and prolonged plasma half-life in human FcRn transgenic mice for treatment of NHL https://www.biorxiv.org/content/10.1101/2023.07.12.548667v1?med=mas
NNV024, a novel humanized anti-CD37 antibody with enhanced ADCC and prolonged plasma half-life in human FcRn transgenic mice for treatment of NHL https://www.biorxiv.org/content/10.1101/2023.07.12.548667v1?med=mas